About Jonathan Northrup
Form D filings for Stingray Therapeutics from 2020 to 2024 list Jonathan Northrup as chief executive officer and director.
Jonathan Northrup first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Northrup in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Northrup works with at each company, as listed on that company's latest Form D.
Stingray Therapeutics, Inc. · Form D, May 14, 2024
SS
Sunil Sharma
Executive officer and director
UB
Uma Bhatt
Executive officer and director